Anakinra

A study has evaluated the long-term response and safety of interleukin-1 receptor antagonist, Anakinra ( Kineret ) in recurrent pericarditis. Fifteen...


Experimental work pointing to a therapy for alleviating mucositis, a common, severe side effect of chemotherapy and irradiation of cancer...


Anakinra ( Kineret ) is a recombinant form of interleukin-1 receptor antagonist. It is the drug of choice for Schnitzler...


Interleukin-36 receptor antagonist deficiency ( DITRA ) is a hereditary auto-inflammatory disease characterized by repeated flares of generalized pustular psoriasis...


Sterile multifocal osteomyelitis with periostitis and pustulosis ( OMPP ) is more commonly referred to as DIRA ( deficiency of...


NLRP12-associated periodic syndrome ( NAPS12 ) is characterized by recurrent periods of fever, combined with various systemic manifestations such as...


Orencia ( Abatacept ) SC ( subcutaneous ) and IV ( intravenous ) is indicated for reducing signs and symptoms,...


Corticosteroids are the mainstay of treatment for immune-mediated diseases, including non-infectious uveitis and ocular inflammation, because they are inexpensive, potent...


All three commonly used TNF blockers ( Infliximab, Etanercept and Adalimumab ) were initially approved for the treatment of rheumatoid...


Two clinical trials of Humira ( Adalimumab ), REVEAL and CHAMPION, have demonstrated promising results in psoriasis. Psoriasis is a...


A Phase III study showed that patients with moderate to severely active Crohn's disease treated with Adalimumab ( Humira )...


Researchers from the Baylor Institute for Immunology Research in Dallas report on the successful treatment of children with systemic onset...


FDA ( U.S. Food and Drug Administration ) approved Humira ( Adalimumab ) for reducing signs and symptoms of active...


The FDA ( U.S. Food and Drug Administration ) approved Humira ( Adalimumab ) for first-line treatment of recent onset...